ALBI分级在肝细胞癌肝功能评估及预后分层的应用及研究进展  

Research advances of ALBI grade for liver function assessment and prognosis stratification

作　　者：詹一 倪才方[1] 仲斌演 田鹏程 ZHAN Yi;NI Caifang;ZHONG Binyan;TIAN Pengcheng(Department of Interventional Radiology,the First Affiliated Hospital of Soochow University,Suzhou 215006,China)

机构地区：[1]苏州大学附属第一医院介入科,江苏苏州215006

出　　处：《实用医学杂志》2023年第3期381-385,共5页The Journal of Practical Medicine

基　　金：国家自然科学基金青年科学基金(编号:81901847)。

摘　　要：目前临床上对于肝癌患者的肝功能评估和治疗相关的预后预测仍以Child-Pugh评分为主,但在实施“精准医学”的年代越显其存在着明显不足之处。本文就近年来利用ALBI分级(白蛋白-胆红素分级)在接受不同方式治疗的肝癌的患者的疗效评估、预后预测方面的应用、ALBI分级的优、缺点加以总结,并将近年来将其应用于预测模型的研究现状进行综述,以为临床工作提供更大的帮助。The major tool for liver function assessment and prognosis stratification for patients with hepatocellular carcinoma is Child-Pugh score.Nevertheless,the accuracy of the Child-Pugh score on this topic is limited by its disadvantages.With the aim to provide better clinical evidence and benefits,the review article summarized the ability of the albumin-bilirubin(ALBI)grade in evaluating the efficacy and predicting the prognosis of various treatments for patients with hepatocellular carcinoma(HCC)as well as the advantages and disadvantages of ALBI classification.In addition,ALBI grade-based prognostic models for HCC were also reviewed.

关 键 词：白蛋白-胆红素分级 肝细胞癌 肝功能 预后 

分 类 号：R735.7[医药卫生—肿瘤]